Assessment of severity of post-ERCP pancreatitis by the drug pain score.

Assessment of severity of post-ERCP pancreatitis by the drug pain score. - Post-ERCP pancreatitis and the drug pain score.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029279

Enrollment

10000

Registered

2017-09-26

Start date

2017-09-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-ERCP pancreatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with consent capability with usual ERCP

Exclusion criteria

Exclusion criteria: 1.minors 2.Patients who had EST. 3.Patients who are undergoing bile duct jejunostomy. 4.Pancreas / biliary stent placement. 5.Patients who had ERCP on non-hospitalization6.Patients with pancreatitis before ERCP (gallstone pancreatitis, obstructive pancreatitis, etc.).

Design outcomes

Primary

Measure	Time frame
Converting analgesic use amount by DPS, establish PEP severity prediction model for reliability prediction of severity of PEP by DPS	—

Secondary

Measure	Time frame
1,DPS shows correlation with the severity criteria of the Ministry of Health, Labor and Welfare 2, DPS shows the severity earlier than the severity criteria of the Ministry of Health, Labor and Welfare 3. Calculate the cutoff value for prediction of PEP severity by DPS	—

Countries

Japan

Contacts

Public ContactRyukichi akashi

Kumamoto City Medical Association Health Care Center Endoscopy

a-kashi@krmc.or.jp096-366-2711

Outcome results